Susquehanna International Group, LLP Genmab A/S Call Options Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	BUY	$26.43 - $32.77 $5,286 - $6,554	200 Added 2.25%	9,100 $272,000
Q4 2023 Feb 14, 2024	SELL	$27.94 - $35.44 $480,568 - $609,568	-17,200 Reduced 65.9%	8,900 $283,000
Q3 2023 Nov 14, 2023	BUY	$35.27 - $42.24 $574,901 - $688,512	16,300 Added 166.33%	26,100 $920,000
Q2 2023 Aug 11, 2023	SELL	$37.4 - $42.94 $3.98 Million - $4.57 Million	-106,500 Reduced 91.57%	9,800 $372,000
Q1 2023 May 16, 2023	BUY	$34.88 - $43.22 $3.26 Million - $4.05 Million	93,600 Added 412.33%	116,300 $4.39 Million
Q4 2022 Feb 14, 2023	SELL	$33.8 - $47.06 $277,160 - $385,892	-8,200 Reduced 26.54%	22,700 $962,000
Q3 2022 Nov 14, 2022	SELL	$31.52 - $373.61 $731,264 - $8.67 Million	-23,200 Reduced 42.88%	30,900 $993,000
Q2 2022 Aug 15, 2022	BUY	$26.83 - $38.57 $1.21 Million - $1.74 Million	45,200 Added 507.87%	54,100 $1.76 Million
Q3 2021 Nov 15, 2021	SELL	$41.55 - $48.72 $2.35 Million - $2.75 Million	-56,500 Reduced 86.39%	8,900 $389,000
Q2 2021 Aug 11, 2021	BUY	$32.88 - $44.57 $154,536 - $209,479	4,700 Added 7.74%	65,400 $2.67 Million
Q1 2021 May 17, 2021	BUY	$30.92 - $44.4 $1.57 Million - $2.25 Million	50,700 Added 507.0%	60,700 $1.99 Million
Q3 2020 Nov 16, 2020	BUY	$33.07 - $38.68 $330,700 - $386,800	10,000 New	10,000 $366,000

232

48.5M

6.8K

27.6K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $15.9B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.